TTRX (STOCKS)
Turn Therapeutics Inc. Common Stock
$3.315000
-0.035000 (-1.04%)
Prev close: $3.350000
Company Information
- Exchange
- XNAS
- Sector
- Health Technology
- Industry
- Pharmaceuticals: Major
- CEO
- Bradley Burnam
- Asset Type
- stocks
- Website
- Visit
Fundamentals
- Market Cap
- $98.75M
- Employees
- 2
- P/E (TTM)
- -25.04
- P/B (TTM)
- 16.96
- Dividend Yield
- —
Technical Indicators
- SMA 10
- —
- SMA 20
- —
- SMA 50
- —
- EMA 9
- —
- EMA 21
- —
- RSI
- —
- MACD State
- —
Recent News
No recent news found for this ticker.
Financial Statements
| Revenues | $0.00 |
| Nonoperating Income/Loss | $2.66M |
| Operating Expenses | $5.86M |
| Depreciation and Amortization | $52.75K |
| Research and Development | $265.57K |
| Other Operating Expenses | $5.54M |
| Operating Income/Loss | -$5.86M |
| Income/Loss From Continuing Operations After Tax | -$3.19M |
| Income/Loss From Continuing Operations Before Tax | -$3.19M |
| Net Income/Loss | -$3.19M |
| Net Income/Loss Attributable To Noncontrolling Interest | $0.00 |
| Net Income/Loss Attributable To Parent | -$3.19M |
| Net Income/Loss Available To Common Stockholders, Basic | -$3.19M |
| Participating Securities, Distributed And Undistributed Earnings/Loss, Basic | $0.00 |
| Preferred Stock Dividends And Other Adjustments | $0.00 |
| Basic Earnings Per Share | -$0.12 |
| Diluted Earnings Per Share | -$0.12 |
| Basic Average Shares | 27,716,045 |
| Diluted Average Shares | 27,716,045 |
| Assets | $12.16M |
| Current Assets | $5.20M |
| Noncurrent Assets | $6.97M |
| Intangible Assets | $922.17K |
| Other Non-current Assets | $6.04M |
| Liabilities | $7.48M |
| Current Liabilities | $6.00M |
| Noncurrent Liabilities | $1.47M |
| Equity | $4.69M |
| Equity Attributable To Noncontrolling Interest | $0.00 |
| Equity Attributable To Parent | $4.69M |
| Liabilities And Equity | $12.16M |
| Net Cash Flow From Operating Activities | -$2.56M |
| Net Cash Flow From Operating Activities, Continuing | -$2.56M |
| Net Cash Flow From Investing Activities | -$152.99K |
| Net Cash Flow From Investing Activities, Continuing | -$152.99K |
| Net Cash Flow From Financing Activities | $6.92M |
| Net Cash Flow From Financing Activities, Continuing | $6.92M |
| Net Cash Flow | $4.20M |
| Net Cash Flow, Continuing | $4.20M |
| Comprehensive Income/Loss | -$3.19M |
| Comprehensive Income/Loss Attributable To Noncontrolling Interest | $0.00 |
| Comprehensive Income/Loss Attributable To Parent | -$3.19M |
| Other Comprehensive Income/Loss | $0.00 |